https://www.firmenpresse.de/pressrelease9317/directed-issue-of-new-shares-in-biotie-therapies-corp-to-institutional-investors.html
Directed issue of new shares in Biotie Therapies Corp. to institutional investors
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 4 DECEMBER 2009at 9.10 p.m.Directed issue of new shares in Biotie Therapies Corp. toinstitutional ...
https://nordiclifescience.org/tag/biotie-therapies-corp/
Biotie Therapies Corp. Archives - NLS
therapiescorparchivesnls
https://www.biocentury.com/article/125439/biotie-somaxon-deal
BioCentury - Biotie, Somaxon deal
BTH1V granted Somaxon an option to exclusively license North American rights to develop and market nalmafene to treat impulse disorders. Somaxon will pay a...
biocenturydeal